Skip to main content
Gulf Pharmaceutical Industries logo

Gulf Pharmaceutical Industries — Investor Relations & Filings

Ticker · JULPHAR ISIN · AEG000201018 Abu Dhabi Securities Exchange Manufacturing
Open in API
Filings indexed 352 across all filing types
Latest filing 2026-05-11 Regulatory Filings
Country AE United Arab Emirates
Listing Abu Dhabi Securities Exchange JULPHAR

About Gulf Pharmaceutical Industries

https://www.Julphar.net

Gulf Pharmaceutical Industries (Julphar) is a prominent pharmaceutical manufacturer and distributor. The company specializes in producing a diverse portfolio of medicines, vaccines, and consumer healthcare products, addressing a broad spectrum of health conditions. Julphar is recognized as one of the largest generic pharmaceutical manufacturers in the Middle East and North Africa, and a leading global producer of insulin. Utilizing internationally accredited, state-of-the-art facilities, it manufactures over one million medicine boxes daily, distributing products to more than 40 countries. The company's operations emphasize high quality and safety standards in its comprehensive manufacturing capabilities.

Recent filings

Filing Released Lang Actions
إيقاف التداول على أسهم شركة الخليج للصناعات الدوائية JULPHAR في 14 مايو 2026 الساعة 11:00 صباحاً
Regulatory Filings Classification · 84% confidence The document is an ADX (Abu Dhabi Securities Exchange) resolution announcing a temporary trading suspension on the shares of Gulf Pharmaceutical Industries. It is a regulatory market notice rather than a corporate earnings report, management update, or formal delisting notice. There are no financial statements or investor presentation content. This aligns with a general regulatory filing/announcement, categorized under Regulatory Filings (RNS).
2026-05-11 English
Suspend trading on Gulf Pharmaceutical Industries-JULPHAR shares on 14 May 2026 at 11:00 AM
Regulatory Filings Classification · 90% confidence The document is a resolution from the Abu Dhabi Securities Exchange suspending trading in a company’s shares ahead of a board meeting. It is an exchange regulatory announcement and does not contain financial statements or management commentary; it simply instructs on compliance. This falls under general regulatory filings (fallback category).
2026-05-11 English
شركة الخليج للصناعات الدوائية محضر اجتماع الجمعية العمومية السنوية المنعقد بتاريخ 25/04/2026
AGM Information Classification · 85% confidence The document is the official minutes of the Annual General Assembly Meeting of Gulf Pharmaceutical Industries (Julphar), containing attendance, quorum, agenda items, resolutions and Q&A from the AGM. This clearly fits the AGM Information category.
2026-05-08 English
Gulf Pharmaceutical Industries Annual General Meeting 25/04/2026 - Minutes
AGM Information Classification · 90% confidence The document text is clearly the official minutes of the Annual General Assembly Meeting (AGM) for Gulf Pharmaceutical Industries (Julphar), detailing attendance, quorum, resolutions passed, votes, and the full Q&A discussion. It is not an earnings release or proxy solicitation, nor a separate regulatory notice—it is the full record of the AGM proceedings. Therefore, it fits the AGM Information category.
2026-05-08 English
شركة الخليج للصناعات الدوائية اعلان اجتماع مجلس الإدارة بتاريخ 14/05/2026 الساعة 11:00
Regulatory Filings Classification · 75% confidence The document is a formal disclosure of a Board of Directors meeting (“الإفصاح عن اجتماع مجلس الإدارة”) listing the date, agenda items (e.g., approval of minutes, unaudited financial results for the quarter ended March 31, 2026), authorized signatory and corporate seal. It is not an actual financial report or transcript, nor does it announce changes in board composition. This type of regulatory notice does not neatly fit other categories, so it defaults to a general Regulatory Filing (RNS).
2026-05-08 Arabic
Gulf Pharmaceutical Industries Announcement of Board Meeting to be held on 14/05/2026 at 11:00
Regulatory Filings Classification · 75% confidence The document is a formal disclosure notice for an upcoming board meeting, providing date, agenda, signatory, etc. It does not contain minutes of a meeting or changes to board composition, nor does it include actual financial results. It is a general regulatory announcement rather than an AGM presentation, management report, or executive change notice. Therefore, it falls under the general "Regulatory Filings" category (RNS).
2026-05-08 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.